Blocking autophagy enhances meloxicam lethality to hepatocellular carcinoma by promotion of endoplasmic reticulum stress

OBJECTIVES: Meloxicam, a selective cyclooxygenase‐2 (COX‐2) inhibitor, has been demonstrated to exert anti‐tumour effects against various malignancies. However, up to now, mechanisms involved in meloxicam anti‐hepatocellular carcinoma effects have remained unclear. MATERIALS AND METHODS: Cell viabil...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cell Prolif
Autors principals: Zhong, Jingtao, Dong, Xiaofeng, Xiu, Peng, Wang, Fuhai, Liu, Ju, Wei, Honglong, Xu, Zongzhen, Liu, Feng, Li, Tao, Li, Jie
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2015
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6496225/
https://ncbi.nlm.nih.gov/pubmed/26481188
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12221
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars